Efficacy of two dosages of dexamethasone administered by submucosal injection on postoperative sequelae after third molar surgery: A retrospective study.


Journal

American journal of dentistry
ISSN: 0894-8275
Titre abrégé: Am J Dent
Pays: United States
ID NLM: 8806701

Informations de publication

Date de publication:
Oct 2022
Historique:
entrez: 19 10 2022
pubmed: 20 10 2022
medline: 22 10 2022
Statut: ppublish

Résumé

A retrospective clinical study was performed to compare the post-operative sequelae of the submucosal administration of two different low dosages of dexamethasone, after the surgical extraction of lower third molars. Data regarding edema, trismus, pain and analgesic consumption were collected from 150 subjects, selecting three equal groups (n= 50): a control group with no administered dexamethasone (G1); submucosal injection of dexamethasone 2 mg/0.5 ml (G2) and submucosal injection of dexamethasone 4 mg/1 ml (G3). Collected data were evaluated at three different time points: T₀ before surgery, T₁ on the third day after surgery and T₂ on the 7th day after surgery. Patients' gender and age were also considered for statistical purposes. The effects on facial swelling reduction were statistically significant in G2 at T₁ in the male subgroup. With trismus, the differences between the time points considered were statistically significant in G2 in the subgroup of subjects younger than 25 years old. Differences in analgesics taken were statistically significant when G1 and G2 were compared at T₁. The submucosal injection of 2 mg/0.5 ml of dexamethasone to subjects younger than 25 years old is enough to reduce trismus. For females and subjects older than 25 years old, it is preferable to administer at least 4 mg of dexamethasone to reduce edema.

Identifiants

pubmed: 36261402

Substances chimiques

Dexamethasone 7S5I7G3JQL
Anti-Inflammatory Agents 0

Types de publication

Clinical Trial

Langues

eng

Pagination

233-237

Informations de copyright

Copyright©American Journal of Dentistry.

Déclaration de conflit d'intérêts

The authors declared no conflicts of interest. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Auteurs

Michele Vasselli (M)

Private practice.

Alvise Camurri Piloni (A)

Private practice.

Christian Greco (C)

Azienda Sanitaria dell'Alto Adige, Merano, Italy.

Davide Porrelli (D)

Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy, dporrelli@units.it.

Lorenzo Bevilacqua (L)

Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.

Michele Maglione (M)

Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH